+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Gilead Sciences Inc - logo

Founded in 1987 Gilead Sciences is a biopharmaceutical company focused on developing innovative treatments for life threatening illnesses. Their areas of research include HIV/AIDs, Liver Diseases, Hematology, Oncology, Cardiovascular and Respiratory disease. Gilead Sciences is based in California, USA and their product portfolio consists of well-known treatments like Atripla, Sovaldi, Zydelig, Viread and many more.

Africa Anti-Rheumatic Drug Market - Forecasts from 2022 to 2027 - Product Thumbnail Image

Africa Anti-Rheumatic Drug Market - Forecasts from 2022 to 2027

  • Report
  • January 2023
  • 78 Pages
  • Africa
From
CAR-T - Pipeline Insight, 2025 - Product Thumbnail Image

CAR-T - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 450 Pages
  • Global
From
From
Sexually Transmitted Infections (STIs) Market Report 2025 - Product Thumbnail Image

Sexually Transmitted Infections (STIs) Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Histoplasmosis Treatment Market Report 2025 - Product Thumbnail Image

Histoplasmosis Treatment Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
From
Precision Cancer Therapeutics, 2022 - Product Thumbnail Image

Precision Cancer Therapeutics, 2022

  • Report
  • November 2022
  • 154 Pages
  • Global
From
From
Pharmacovigilance Market Report 2025 - Product Thumbnail Image

Pharmacovigilance Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
From
From
Orphan Drugs Market Report 2025 - Product Thumbnail Image

Orphan Drugs Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
Small Molecule Drug Discovery Market Report 2025 - Product Thumbnail Image

Small Molecule Drug Discovery Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
Loading Indicator